Urinary C-Type natriuretic peptide. A new heart failure biomarker

JACC: Heart Failure

Volumn 1, Issue 2, 2013, Pages 170-177

  Zakeri, Rosita ^a   Sangaralingham, S Jeson ^a   Sandberg, Sharon M ^a   Heublein, Denise M ^a   Scott, Christopher G ^a   Burnett, John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute decompensated heart failure; Biomarkers; C type natriuretic peptide; Outcomes

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C TYPE NATRIURETIC PEPTIDE 22; C TYPE NATRIURETIC PEPTIDE 53; KIDNEY INJURY MOLECULE 1; N TERMINAL C TYPE NATRIURETIC PEPTIDE 53; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EVENT FREE SURVIVAL; FEMALE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; SURVIVAL RATE; URINALYSIS; URINARY EXCRETION;

AGED; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, C-TYPE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 84877998409     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2012.12.003     Document Type: Article

References (28)

1. Hunt S.A., Abraham W.T., Chin M.H., et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009, 53:e1-e90.
2. Bettencourt P., Azevedo A., Pimenta J., Frioes F., Ferreira S., Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004, 110:2168-2174.
3. Lee D.S., Vasan R.S. Novel markers for heart failure diagnosis and prognosis. Curr Opin Cardiol 2005, 20:201-210.
4. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008, 358:2148-2159.
5. Adams K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005, 149:209-216.
6. Smith G.L., Lichtman J.H., Bracken M.B., et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 2006, 47:1987-1996.
7. Damman K., Van Veldhuisen D.J., Navis G., et al. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 2010, 96:1297-1302.
8. Jungbauer C.G., Birner C., Jung B., et al. Kidney injury molecule-1 and N-acetyl-beta-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome. Eur J Heart Failure 2011, 13:1104-1110.
9. Collins S.P., Hart K.W., Lindsell C.J., et al. Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events. Eur J Heart Fail 2012, 14:1020-1029.
10. Totsune K., Takahashi K., Murakami O., et al. Natriuretic peptides in the human kidney. Hypertension 1994, 24:758-762.
11. Sangaralingham S.J., Heublein D.M., Grande J.P., et al. Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging. Am J Physiol Renal Physiol 2011, 301:F943-F952.
12. Wu C., Wu F., Pan J., Morser J., Wu Q. Furin-mediated processing of Pro-C-type natriuretic peptide. J Biol Chem 2003, 278:25847-25852.
13. Kojima M., Minamino N., Kangawa K., Matsuo H. Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP). FEBS Lett 1990, 276:209-213.
14. Mattingly M.T., Brandt R.R., Heublein D.M., Wei C.M., Nir A., Burnett J.C. Presence of C-type natriuretic peptide in human kidney and urine. Kidney Int 1994, 46:744-747.
15. McKee P.A., Castelli W.P., McNamara P.M., Kannel W.B. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971, 285:1441-1446.
16. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-470. Modification of Diet in Renal Disease Study Group.
17. Stingo A.J., Clavell A.L., Heublein D.M., Wei C.M., Pittelkow M.R., Burnett J.C. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol 1992, 263:H1318-H1321.
18. Costello-Boerrigter L.C., Boerrigter G., Redfield M.M., et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2006, 47:345-353.
19. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172. discussion 207-12.
20. Cataliotti A., Giordano M., De Pascale E., et al. CNP production in the kidney and effects of protein intake restriction in nephrotic syndrome. Am J Physiol Renal Physiol 2002, 283:F464-F472.
21. Totsune K., Takahashi K., Ohneda M., Itoi K., Murakami O., Mouri T. C-type natriuretic peptide in the human central nervous system: distribution and molecular form. Peptides 1994, 15:37-40.
22. Hagiwara H., Sakaguchi H., Itakura M., et al. Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J Biol Chem 1994, 269:10729-10733.
23. Kalra P.R., Clague J.R., Bolger A.P., et al. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation 2003, 107:571-573.
24. Stingo A.J., Clavell A.L., Aarhus L.L., Burnett J.C. Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol 1992, 262:H308-H312.
25. Del Ry S., Passino C., Maltinti M., Emdin M., Giannessi D. C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity. Eur J Heart Fail 2005, 7:1145-1148.
26. Ng L.L., Geeranavar S., Jennings S.C., Loke I., O'Brien R.J. Diagnosis of heart failure using urinary natriuretic peptides. Clin Sci (Lond) 2004, 106:129-133.
27. Bentzen H., Pedersen R.S., Nyvad O., Pedersen E.B. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure. Int J Cardiol 2004, 93:121-130.
28. Kalra P.R., Clague J.R., Coats A.J., Anker S.D., Poole-Wilson P.A., Struthers A.D. C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure. Clin Sci (Lond) 2010, 118:71-77.